KBL-697
- Generic Name
- KBL-697
A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- KoBioLabs
- Target Recruit Count
- 80
- Registration Number
- NCT04911751
- Locations
- 🇺🇸
Indago Research and Health Center, Hialeah, Florida, United States
🇺🇸Clinical Science Institute, Santa Monica, California, United States
🇦🇺Veracity Clinical Trials Ltd, Woolloongabba, Queensland, Australia
A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- KoBioLabs
- Registration Number
- NCT04898348
- Locations
- 🇦🇺
The Royal Melbourne Hospital, Melbourne, Victoria, Australia
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- KoBioLabs
- Target Recruit Count
- 36
- Registration Number
- NCT04056130
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath